US Taiwan Precision Medicine Forum

The first BIO Asia-Taiwan 2021 serial event, Taiwan-US bilateral industry-university-research experts are invited to share precision health-related genetic testing and treatment and the progress of cloud computing for biomedical data.

*Agenda*
◎ 9:00-9:10 Opening Remarks
◇ Dr. Chung-Hsiun Wu, President, The Development Center for Biotechnology & Director, BPIPO
◇ Mr. Wei Ding, Director, Investment and Trade Office, Taipei Economic and Cultural Office in New York
◇ Ms. Debbie Hart, President and CEO, New Jersey affiliate of the Biotech Innovation Organization
◇ Mr. Kurt Imhof, Vice President, Policy & Public Affairs, Life Sciences Pennsylvania

◎ 9:10-9:30 Precision Medicine in Rare Disease
Dr. Adam Jones, Head of Medical Affairs, International, Amicus Therapeutics

◎ 9:30-9:50 Genetics of Alzheimer’s Disease
Dr. Li-San Wang, Professor, Pathology and Laboratory Medicine, University of Pennsylvania

◎ 9:50-10:10 Homology Medicines’ AAVHSC Gene Therapy and Gene Editing Technology Platform
Ms. Kristi Sarno, Senior Director Business Development & Corporate Strategy, Homology Medicines, Inc.

◎ 10:10-10:30 The Taiwan Precision Medicine Initiative
Dr. Pui-Yan Kwok, M.D, Distinguished Research Fellow and Director (Academician), Institute of Biomedical Sciences, Academia Sinica, Taiwan

◎ 10:30-10:50 Advancing precision medicine with next generation genetic testing and gene therapy
Dr. Wuh-Liang Hwu, M.D., Professor, Department of Medical Genetics, National Taiwan University Hospital

◎ 10:50-11:10 National Biomedical Data Service and Cloud Computing Platform for Genomic data analysis
Dr. Yu-Tai Wang, Director, Technology for AIoT & Biomedical Information Service Division, National Center for High-Performance Computing

◎ 11:10-11:40 Panel Discussion / Q&A